Ansarada Education

A pandemic-proof industry? Pharma & Biotech thrive in a COVID world

Technology in healthcare can only go in one direction.

2021, wrapped

The best of a year of ups and downs.

Four key M&A dealmaking trends to watch in 2023

We interviewed twelve leading M&A dealmakers across regions and industries to get their predictions and trends to watch for the year ahead.

Are we on the brink of a global insolvency tsunami?

A wave of insolvencies is imminent, according to expert restructuring firm – so how can Directors worldwide turn the impacts of COVID into long-lasting, positive change? Virgin Australia, Travelex and Europoles demonstrate how it’s done.

Are we on the brink of a global insolvency tsunami?

Four key M&A dealmaking trends to watch in 2023

We interviewed twelve leading M&A dealmakers across regions and industries to get their predictions and trends to watch for the year ahead.

2021, wrapped

The best of a year of ups and downs.

A pandemic-proof industry? Pharma & Biotech thrive in a COVID world

Technology in healthcare can only go in one direction.

BGF’s David Bellis: “Buy and Build” strategy gains traction amid improved market sentiment

David Bellis of BGF highlights a resurgence of optimism in the UK&I M&A landscape as businesses begin to recover from the impact of high interest rates and inflation.

SDCL’s Joni Koch: Energy transition deals to continue in the UK&I

Joni Koch has an optimistic outlook for UK&I deal-making in the energy transition sector.

BGF’s David Bellis: “Buy and Build” strategy gains traction amid improved market sentiment

David Bellis of BGF highlights a resurgence of optimism in the UK&I M&A landscape as businesses begin to recover from the impact of high interest rates and inflation.